Austin G. Duffy

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations

Life Sciences, Immunology, Oncology +17

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

Austin G. Duffy, Susanna V. Ulahannan, Oxana Makorova-Rusher et al. · Journal of Hepatology · 2016 · 818 citations

Medicine, Oncology, Surgery +12

Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)

Austin G. Duffy, Marinela Capanu, Ghassan K. Abou‐Alfa et al. · Journal of Surgical Oncology · 2008 · 469 citations

Medicine, Oncology, Surgery +15

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

Fidel David Huitzil Melendez, Marinela Capanu, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2010 · 352 citations · Full text

Medicine, Oncology, Surgery +17